Investors Buy High Volume of Put Options on Oscar Health (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was the recipient of some unusual options trading activity on Friday. Traders purchased 13,581 put options on the stock. This represents an increase of 35% compared to the average daily volume of 10,049 put options.

Insider Activity at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 24.39% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors and hedge funds have recently bought and sold shares of OSCR. JPMorgan Chase & Co. raised its position in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after buying an additional 8,051,379 shares during the period. BIT Capital GmbH increased its stake in Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after acquiring an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C raised its position in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the period. Nuveen LLC purchased a new position in shares of Oscar Health during the 1st quarter worth $29,684,000. Finally, Gilder Gagnon Howe & Co. LLC increased its position in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after purchasing an additional 2,151,256 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on OSCR shares. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price objective for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen cut shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.08.

Oscar Health Trading Down 5.6%

NYSE OSCR traded down $0.84 on Wednesday, reaching $14.17. 6,575,965 shares of the company were exchanged, compared to its average volume of 4,336,075. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The business's fifty day moving average price is $13.73 and its 200 day moving average price is $14.59. The stock has a market capitalization of $3.55 billion, a P/E ratio of -709.40 and a beta of 1.75. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter in the previous year, the company posted $0.62 EPS. The company's revenue was up 42.2% compared to the same quarter last year. Analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.